Janisova, L.; Gruzinov, A.; Zaborova, O.V.; Velychkivska, N.; Vaněk, O.; Chytil, P.; Etrych, T.; Janoušková, O.; Zhang, X.; Blanchet, C.;
et al. Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins. Pharmaceutics 2020, 12, 106.
https://doi.org/10.3390/pharmaceutics12020106
AMA Style
Janisova L, Gruzinov A, Zaborova OV, Velychkivska N, Vaněk O, Chytil P, Etrych T, Janoušková O, Zhang X, Blanchet C,
et al. Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins. Pharmaceutics. 2020; 12(2):106.
https://doi.org/10.3390/pharmaceutics12020106
Chicago/Turabian Style
Janisova, Larisa, Andrey Gruzinov, Olga V. Zaborova, Nadiia Velychkivska, Ondřej Vaněk, Petr Chytil, Tomáš Etrych, Olga Janoušková, Xiaohan Zhang, Clement Blanchet,
and et al. 2020. "Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins" Pharmaceutics 12, no. 2: 106.
https://doi.org/10.3390/pharmaceutics12020106
APA Style
Janisova, L., Gruzinov, A., Zaborova, O. V., Velychkivska, N., Vaněk, O., Chytil, P., Etrych, T., Janoušková, O., Zhang, X., Blanchet, C., Papadakis, C. M., Svergun, D. I., & Filippov, S. K.
(2020). Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins. Pharmaceutics, 12(2), 106.
https://doi.org/10.3390/pharmaceutics12020106